French biotech discontinues all clinical activities, shuts down US site

cafead

Administrator
Staff member
  • cafead   Feb 04, 2025 at 06:12: PM
via Valerio Therapeutics is ending all clinical trials, including an ongoing phase 1/2 study for its investigational “DNA decoy” candidate designed to treat recurrent solid tumors.

article source